145 related articles for article (PubMed ID: 37788795)
1. Neoadjuvant photodynamic therapy as a therapeutic alternative in multiple basal cell carcinoma induced by radiotherapy.
Espiñeira Sicre J; García Sirvent L; Ruiz Sánchez J; García Fernández L; Soro Martínez P; Miralles Botella J; Fernández Fornos L; Onrubia Pintado JA; Cuesta Montero L
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103820. PubMed ID: 37788795
[TBL] [Abstract][Full Text] [Related]
2. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
3. Combined CO
Ferrara F; Lacava R; Barisani A; Messori S; Patrizi A; Bardazzi F; Vaccari S
J Dtsch Dermatol Ges; 2019 Dec; 17(12):1251-1256. PubMed ID: 31814292
[TBL] [Abstract][Full Text] [Related]
4. Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up.
Gómez C; Cobos P; Alberdi E
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102176. PubMed ID: 33429099
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
6. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
7. Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.
Maytin EV; Kaw U; Ilyas M; Mack JA; Hu B
Photodiagnosis Photodyn Ther; 2018 Jun; 22():7-13. PubMed ID: 29471147
[TBL] [Abstract][Full Text] [Related]
8. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
Wolfe CM; Green WH; Hatfield HK; Cognetta AB
J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
[TBL] [Abstract][Full Text] [Related]
9. Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas.
Rizzo JM; Segal RJ; Zeitouni NC
Photodiagnosis Photodyn Ther; 2018 Mar; 21():58-62. PubMed ID: 29102653
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy for basal cell carcinoma.
Fargnoli MC; Peris K
Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
[TBL] [Abstract][Full Text] [Related]
13. Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma.
Shokrollahi K; Javed M; Aeuyung K; Ghattaura A; Whitaker IS; O'Leary B; James W; Murison M
Ann Plast Surg; 2014 Nov; 73(5):552-8. PubMed ID: 23407256
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
[TBL] [Abstract][Full Text] [Related]
18. Combination curettage and modified ALA-PDT for multiple basal cell carcinomas of the face and head.
Liao C; Zhang G; Wang P; Sun X; Wang X
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102393. PubMed ID: 34116251
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients.
Guleng GE; Helsing P
Clin Exp Dermatol; 2012 Jun; 37(4):367-9. PubMed ID: 22420420
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
